A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Markus Renschler, MD
Cyteir Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California San Francisco
San Francisco, California, United States
- Stanford Comprehensive Cancer Center
Stanford, California, United States
- Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
- Florida Cancer Specialists and Research Institute
Sarasota, Florida, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- John Theurer Cancer Center at Humc
Hackensack, New Jersey, United States
- Nyu Langone Health
New York, New York, United States
- Oklahoma University-Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
- Thomas Jefferson University, Sidney Kimmel Cancer Center
Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute at Tennessee Oncology
Nashville, Tennessee, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- University of Washington Seattle Cancer Center
Seattle, Washington, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2019
- Primary completion
- 30 Nov 2024
- Completion
- 20 Dec 2024
- Last update posted
- 24 Dec 2024
- Registered enrollment
- 169
- Registry id
- NCT03997968
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.